STAT Plus: Pharmalittle: Pfizer says Covid-19 vaccine could be ready by fall for emergency use; an aggressive pitch to reopen the U.S.
Hello, everyone, and welcome to the middle of the week. Yes, we know, it can be hard to tell sometimes which day is which, but here we are. So consider it an accomplishment, given the challenges and stress confronting us all, and treat yourself to a hot cup of stimulation. A little focus is a good thing, after all. We are rifling through our stash of hazelnut, in fact. Meanwhile, here is a fresh pile of tidbits to help you along. We hope today is productive and manageable. And remember, keep on the sunny side, and keep safe. …
Pfizer (PFE) has accelerated the timetable for testing a Covid-19 vaccine and it could be ready for emergency use in the fall if it proves safe in testing, The Wall Street Journal reports. Testing has already started in Germany and could start in the U.S. as early as next week if health regulators sign off. Results could come as early as next month, but Pfizer would need to do more testing to make sure the vaccine works safely. If testing is successful, Pfizer could start distribution on an emergency basis in the fall and receive approval for widespread distribution by year’s end.
